You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study
|
|---|---|
| Published in |
Frontiers in Pharmacology, July 2022
|
| DOI | 10.3389/fphar.2022.916641 |
| Pubmed ID | |
| Authors |
Kurt Stocker, Matthias Hartmann, Steffen Reissmann, Andreas Kist, Matthias E. Liechti |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 17% |
| Netherlands | 1 | 17% |
| Switzerland | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 23 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 22% |
| Student > Master | 2 | 9% |
| Student > Ph. D. Student | 2 | 9% |
| Other | 1 | 4% |
| Unspecified | 1 | 4% |
| Other | 3 | 13% |
| Unknown | 9 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 5 | 22% |
| Neuroscience | 3 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Biochemistry, Genetics and Molecular Biology | 1 | 4% |
| Nursing and Health Professions | 1 | 4% |
| Other | 3 | 13% |
| Unknown | 9 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2022.
All research outputs
#15,681,540
of 25,287,709 outputs
Outputs from Frontiers in Pharmacology
#5,283
of 19,505 outputs
Outputs of similar age
#204,647
of 426,081 outputs
Outputs of similar age from Frontiers in Pharmacology
#259
of 1,346 outputs
Altmetric has tracked 25,287,709 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,505 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,081 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 1,346 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.